发明名称 Method for measuring heparin
摘要 A method for assaying body fluid samples containing heparin and a diagnostic kit are described. Since the reactions go to completion, timing of the assay is not required. The sample is mixed with a heparin-dependent protease inhibitor and either a heparin-independent irreversible inhibitor or a protease substrate. The coagulation enzyme (protease) is then added in a limiting quantity and it either distributes between the heparin-dependent inhibitor and the heparin-indepedent irreversible inhibitor, or the heparin-dependent inhibitor and the protease substrate. The distribution pattern of complex formation of the protease with the two inhibitors or the level of product of the protease-catalyzed hydrolysis of the substrate are used as measures of the heparin activity. The irreversible inhibitor is a peptidyl chloromethyl ketone and the substrate is a synthetic chromogenic or fluorogenic compound that produces a readily measured signal.
申请公布号 US5308755(A) 申请公布日期 1994.05.03
申请号 US19920895078 申请日期 1992.06.08
申请人 RESEARCH CORPORATION TECHNOLOGIES, INC. 发明人 NESHEIM, MICHAEL E.;MANUEL, REGINALD P.
分类号 C12Q1/56;G01N33/573;G01N33/86;(IPC1-7):C12Q1/56 主分类号 C12Q1/56
代理机构 代理人
主权项
地址